Advertisement
Canada markets closed

  • S&P/TSX

    24,471.17
    +168.91 (+0.70%)
     

  • S&P 500

    5,815.03
    +34.98 (+0.61%)
     

  • DOW

    42,863.86
    +409.74 (+0.97%)
     

  • CAD/USD

    0.7266
    -0.0011 (-0.16%)
     

  • CRUDE OIL

    75.49
    -0.36 (-0.47%)
     

  • Bitcoin CAD

    86,222.92
    -644.30 (-0.74%)
     

  • XRP CAD

    0.73
    -0.01 (-1.75%)
     

  • GOLD FUTURES

    2,674.20
    +34.90 (+1.32%)
     

  • RUSSELL 2000

    2,234.41
    +45.99 (+2.10%)
     

  • 10-Yr Bond

    4.0730
    -0.0230 (-0.56%)
     

  • NASDAQ

    18,342.94
    +60.89 (+0.33%)
     

  • VOLATILITY

    20.46
    -0.47 (-2.25%)
     

  • FTSE

    8,253.65
    +15.92 (+0.19%)
     

  • NIKKEI 225

    39,605.80
    +224.91 (+0.57%)
     

  • CAD/EUR

    0.6642
    -0.0011 (-0.17%)
     

Celanese (CE) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks Equity Research
·2 min read

For the quarter ended March 2024, Celanese (CE) reported revenue of $2.61 billion, down 8.5% over the same period last year. EPS came in at $2.08, compared to $2.01 in the year-ago quarter.

The reported revenue represents a surprise of -5.01% over the Zacks Consensus Estimate of $2.75 billion. With the consensus EPS estimate being $1.91, the EPS surprise was +8.90%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Celanese performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net Sales- Acetyl Chain: $1.26 billion versus $1.19 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +0.9% change.

  • Net Sales- Inter segment eliminations: -$28 million versus -$23.69 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +3.7% change.

  • Net Sales- Engineered Materials: $1.38 billion compared to the $1.56 billion average estimate based on five analysts. The reported number represents a change of -15.5% year over year.

  • Operating EBITDA- Acetyl Chain: $353 million versus the five-analyst average estimate of $337.65 million.

  • Operating EBITDA- Engineered Materials: $303 million versus $304.42 million estimated by five analysts on average.

  • Operating EBITDA- Other Activities: -$73 million versus -$74.95 million estimated by four analysts on average.

View all Key Company Metrics for Celanese here>>>

Shares of Celanese have returned -2.1% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Celanese Corporation (CE) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research